CXCR4 and cancer: Other CXCR4 inhibitors like plerixafor or balixafortide have already been tested against several types of cancers combined with chemotherapy or cytostatic drugs for improved chemosensitivity and response rates without showing severe side effects linked to bone marrow dysregulation [24,25].